WASHINGTON, Jan. 30 -- Food and Drug Administration has issued a notice called: FDA Rare Disease Innovation Hub Future Programming; Request for Comments.
The notice was published in the Federal Register on Jan. 30 by Lowell M. Zeta, Acting Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or the Agency) is announcing the following request for comments for a future public workshop series entitled "Rare disease Innovation, Science, and Exploration (RISE) Workshop." The purpose of the public workshops is to focus on challenges that are common to multiple diseases or a class of diseases, and for which evolving science offers innovative solutions. The workshops will primarily...